openPR Logo
Press release

Nuclear Medicine Or Radiopharmaceuticals Market To Grow At A 7.6% CAGR By 2028: Size, Share, Growth And Trends

Nuclear Medicine Or Radiopharmaceuticals Market To Grow At

Market Overview:
The Nuclear Medicine or Radiopharmaceuticals Market was valued at USD 5700 million in 2021 and is expected to reach USD 9520 million by the year 2028, at a CAGR of 7.6%.

The practice of nuclear medicine involves the use of radioactive materials in diagnostic or treatments, primarily for the treatment of various cancers. Small quantities of radioactive chemicals known as radiotracers are used in nuclear medicine throughout the imaging or diagnostic procedure. Usually administered intravenously, breathed, or ingested by the patient, these radiotracers localize to particular organs and produce radiation. As it goes through the area to be studied, the radiotracer emits energy in the form of gamma rays. A specialized camera and computer detect these gamma rays to produce images of the inside of the body.

Read More: https://introspectivemarketresearch.com/reports/nuclear-medicine-or-radiopharmaceuticals-market/

Market Dynamics:
Driver:
Over the years, a significant concern for humanity has been the rise in the number of people suffering from inflammatory, cardiovascular, and cancerous diseases. The old approaches used to treat these illnesses don't work as well as a more accurate diagnosis and focused approach to treatment. Additionally, several nuclear treatments have been created to treat the rising incidence of heart disease and cancer, encouraging the growth of the Nuclear Medicine or Radiopharmaceuticals market over the anticipated time frame. The market is further bolstered by the recent identification of brand-new, effective therapeutic uses for radiopharmaceuticals in oncology and cardiology prognosis, supporting the industry's growth in the anticipated time frame.

Opportunities:
New clinical prospects in radiation therapy are anticipated to arise as the use of sophisticated SPECT/CT and PET/CT scanners increases. Monoclonal antibodies, radioisotopes, and immunology have been combined to find radioisotopes with exceptional specificity for cancer detection and therapy, driving development and progress in this field. Additionally, a new area in nuclear medicine has been created by theragnostic, a combination of single medicines used for both therapeutic and diagnostic objectives. This cutting-edge procedure can be used to give the patient a targeted and individualized treatment.

The Report Will Include A Major Chapter
• Patent Analysis
• Regulatory Framework
• Technology Roadmap
• BCG Matrix
• Heat Map Analysis
• Price Trend Analysis
• Investment Analysis
• Company Profiling and Competitive Positioning
• Industry Value Chain Analysis
• Market Dynamics and Factors
• Porter's Five Forces Analysis
• Pestle Analysis
• SWOT Analysis

Know More About the Global Trends Impacting the Future, Download A PDF Sample@:
https://introspectivemarketresearch.com/request/15924

Key Prominent Players in The Nuclear Medicine or Radiopharmaceuticals Market
• Actinium Pharmaceuticals Inc. (US)
• Alliance Medical (UK)
• Avid Bioservices Inc (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• Bracco Diagnostics Inc. (Italy)
• Cardinal Health Inc. (US)
• GE Healthcare (US)
• Ion Beam Applications S.A (Belgium)
• Jubilant Pharma (India)
• Lantheus Medical Imaging Inc. (US)
• Medi-Radiopharma Ltd (Hungary)
• Nordion Inc. (Canada)
• Novartis/Advanced Accelerator Applications (France)
• Positron Corporation (US)
• Radiopharm Theranostics Ltd. (US), and other major players.

Segmentation of The Nuclear Medicine or Radiopharmaceuticals Market
By Type
• Diagnostic
• Therapeutic
• Research

By Modality
• Single-Photon Emission Computed Tomography (SPECT) Radioisotopes
• Positron Emission Tomography (PET) Radioisotopes
• Beta Emitters
• Alpha Emitters
• Others

By Application
• Oncology
• Thyroid
• Cardiology
• Neurology
• Others

By End User
• Hospitals and Diagnostic Centers
• Research Institutes

Make An Inquiry For Report Customization (Must Use Business Contact Details For High Preference):
https://introspectivemarketresearch.com/inquiry/15924

Regional Analysis of Nuclear Medicine or Radiopharmaceuticals Market:
The North American region is expected to have the highest share of the Nuclear Medicine or Radiopharmaceuticals market attributed to the highly developed healthcare sector and the rapid adoption of advanced nuclear technologies for diagnosing and developing efficient therapeutic procedures. Moreover, an increase in the number of medical tourism and the growing prevalence of various cancers coupled with new product launches having advanced features are expected to stimulate the growth of the market in this region. Furthermore, the supportive government policies and fundings for the development of novel techniques are the main factors driving the expansion of the market in this region.
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of SA)

COVID-19 Impact on Nuclear Medicine or Radiopharmaceuticals Market
The emergence and worldwide spread of COVID-19, an infectious disease caused by the novel coronavirus SARS-CoV-2, has resulted in a continuing pandemic threat to global health. Nuclear medicine techniques can be used for functional imaging of (pathological)physiological processes at the cellular or molecular level and treatment approaches based on targeted delivery of therapeutic radionuclides. Ongoing development of radiolabeling procedures has significantly enhanced the accessibility of radiopharmaceuticals for in vivo molecular imaging or targeted radionuclide therapy, but their use for biosafety threats such as SARS-CoV-2 is confined by the contagious nature of these agents. Moreover, as the hospitals were full of patients suffering from COVID-19, the diagnostic and therapeutic usage of CT/PET scans were restricted.

The report covers exhaustive analysis on:
• The market size and industry growth rate of the global and regional market across various segments
• Based on extensive primary and secondary research this report provides comprehensive and granular data
• Key technological advancements and market trends that shape the market
• Brand dynamics and distribution trends in order to effectively plan strategies in the forecast period 2023-2029
• Key companies operating in the global Nuclear Medicine or Radiopharmaceuticals market and their market share

Buy the Latest Version of this Report @

https://introspectivemarketresearch.com/checkout/?user=1&_sid=15924

Read More Related Report: -

https://introspectivemarketresearch.com/reports/coenzyme-q10-ubiquinone-market

https://introspectivemarketresearch.com/reports/gourmet-salts-market/

https://introspectivemarketresearch.com/reports/indoor-farming-market/

Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1 773 382 1049

About Us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nuclear Medicine Or Radiopharmaceuticals Market To Grow At A 7.6% CAGR By 2028: Size, Share, Growth And Trends here

News-ID: 3036918 • Views:

More Releases from Introspective Market Research

Absorbed Glass Mat (AGM) Separator Batteries Market To Reach USD 38.55 Billion by 2032.
Absorbed Glass Mat (AGM) Separator Batteries Market To Reach USD 38.55 Billion b …
Absorbed Glass Mat (AGM) Separator Batteries Market was valued at USD 23.81 Billion in 2023 and is expected to reach USD 38.55 Billion by the year 2032. Absorbed Glass Mat (AGM) batteries are advanced lead-acid batteries designed for higher electrical output, making them ideal for start-stop vehicle systems and increasingly popular in electric vehicles. Unlike conventional batteries, AGM batteries are sealed, maintenance-free, non-spillable, and highly resistant to vibrations, with improved
Automotive Fuel Injection Systems Market: Business Research Analysis By 2032
Automotive Fuel Injection Systems Market: Business Research Analysis By 2032
Automotive Fuel Injection Systems are crucial for optimizing engine performance, fuel efficiency, and reducing emissions in modern vehicles. These systems, which include fuel injectors, a fuel pump, a pressure regulator, and an ECU, precisely control fuel delivery either through Direct Fuel Injection or Port Fuel Injection. With growing demand for fuel-efficient, environmentally-friendly vehicles, advanced technologies like Gasoline Direct Injection (GDI) and Common Rail Diesel Injection (CRDI) are driving market growth
North America Coal to Liquid Market to Reach 3.02 Mn at CAGR 8.1% | DKRW Energy, Headwaters, Global Energy, Rentech
North America Coal to Liquid Market to Reach 3.02 Mn at CAGR 8.1% | DKRW Energy, …
North America Coal to Liquid Market Size Was Valued at USD 1.50 Billion in 2023, and is Projected to Reach USD 3.02 Billion by 2032, Growing at a CAGR of 8.1% From 2024-2032. The North America Coal to Liquid (CTL) market is a niche but evolving segment within the broader energy and fuel industry. CTL technology involves converting coal into liquid hydrocarbons, such as diesel, gasoline, and other petroleum products, through
India Green Hydrogen Market Next Big Thing | Adani Green Energy, JSW Energy, NTPC Limited, Tata Power
India Green Hydrogen Market Next Big Thing | Adani Green Energy, JSW Energy, NTP …
IMR posted new studies guide on India Green Hydrogen Market Insights with self-defined Tables and charts in presentable format. In the Study you may locate new evolving Trends, Drivers, Restraints, Opportunities generated via targeting market related stakeholders. The boom of the India Green Hydrogen marketplace became specifically driven with the aid of the growing R&D spending internationally. India Green Hydrogen Market Size Was Valued at USD 2.51 Billion in 2023, and

All 5 Releases


More Releases for Radiopharm

2025-2034 Radiopharmaceutical Theranostics Market Roadmap: Insights for Competit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Radiopharmaceutical Theranostics Market Size By 2025? The market size of radiopharmaceutical theranostics has experienced rapid growth in the past few years. It is projected to increase from $2.88 billion in 2024 to $3.27 billion in 2025, with a compound annual growth rate (CAGR) of 13.7%.
Strong Growth Ahead: Radiopharmaceutical Theranostics Market Size To Grow At Are …
The Radiopharmaceutical Theranostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Radiopharmaceutical Theranostics Market Size Expected to Be by 2034? The size of the radiopharmaceutical theranostics market has seen rapid expansion in the recent past. The market is expected to increase from
The Surge In Cancer Incidence Boosts Radiopharmaceutical Theranostics Market Gro …
How Are the key drivers contributing to the expansion of the radiopharmaceutical theranostics market? The growth of the radiopharmaceutical theranostics market is projected to be driven by the increasing occurrence of cancer. Cancer is a complicated disease characterized by the abnormal and excessive growth of cells, which can ultimately spread to other regions of the body. Radiopharmaceutical theranostics aids in fighting cancer through personalized and targeted methodologies. For example, as per
Comprehensive Market Analysis on Theranostics Market projected to reach USD 5.4 …
Theranostics Market Scope: Market size value in 2023 - USD 1.9 Billion Market size value in 2030 - USD 5.4 Billion CAGR (2023-2030) - 16.2% Forecast Period - 2023-2030 Segments Covered - Product Type, Application, End Users and Region Geographies Covered - North America, Europe, Asia Pacific, and Row Sample of Companies Covered - Abbott Laboratories, Advanced Accelerator Applications, AmeriPath, Bayer AG, Cardinal Health, Curium, GE HealthCare Technologies, Lantheus Medical Imaging, NuView Life
Radiopharmaceutical Theranostics Market Report 2024 Latest Insights, Growth Rate …
"The new report published by The Business Research Company, titled Radiopharmaceutical Theranostics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the radiopharmaceutical theranostics market size has grown rapidly in recent years. It will grow from $2.51 billion in
Theranostics Market Report 2024: Strategies And Recent Developments | Abbott Lab …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2736 The Business Research Company offers in-depth market insights through Theranostics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The theranostics market size has grown rapidly in recent years. It will grow